Compare Hormel Foods Corp (HRL) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hormel Foods Corp vs Kymera Therapeutics Inc. Common Stock — how do they compare? Hormel Foods Corp trades at $19.86 (market cap $10.57B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: Hormel Foods Corp is the larger of the two by market cap, and Hormel Foods Corp pays a 6.09% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hormel Foods Corp for 99 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| HRL | KYMR | |
|---|---|---|
Market Cap | $10.57B | $8.87B |
Volume | 4,381,202 | 779,107 |
Sector | Consumer Staples | Health |
52-Week High | $26.50 | $127.31 |
52-Week Low | $19.19 | $55.80 |
Typical Hold Time | 99 Days | 0 Days |
Enterprise Value | $12.56B | $8.26B |
Dividend Yield | 6.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hormel Foods (HRL) trades at $19.81, up 2.64% today, with a mixed technical outlook showing bearish moving averages but oversold RSI signals. The company reported Q2 2026 EPS of $0.37, beating estimates, but net income margin has declined to 2.82% in 2026 from 6.75% in 2024. Recent news highlights the $1.06 billion Brakebush acquisition to expand its chicken business, while the dividend yield remains a key attraction with 60 consecutive years of increases.
The stock offers a compelling dividend history but faces growth challenges with shrinking profit margins and elevated P/E of 30.98. Analyst consensus is cautious with a $25 price target, and the acquisition integration poses execution risk. Upside depends on successful cost management and foodservice expansion, while margin pressure and high payout ratios remain headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hormel Foods Corp
Hormel Foods is a protein-focused branded food company. Its brands include its namesake Hormel, Spam, Jennie-O, Dinty Moore, Applegate, Wholly Guacamole, and Skippy. The vast majority of the company's revenue is U.S.-based: 64% U.S. retail, 28% U.S. food service, and 8% international. By product type, in fiscal 2021, 23% of revenue was shelf-stable foods, 18% was poultry (branded and commodity), 55% was other perishable food, and 3% was other, primarily nutritional products. The company holds the number-one market position in shelf-stable meat, shelf-stable ready meals, pepperoni, natural/organic deli meat, and guacamole and the number-two position in turkey, bacon, chilled ready meals, and peanut butter.
Read more on HRL →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
